VELO on MSN

My personal best of 2025: The year pro cycling hit a new golden era

In the turbo-charged 2025 season that sent pro racing into overdrive, unplugging can be as important as staying plugged in.

FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...